Nachrichten zur Teva Pharmaceutical Industries Limited Aktie

Stada steigert Arznei-Produktion in Corona-Krise auf Rekord

BAD VILBEL (dpa-AFX) - Der Pharmakonzern Stada hat in der Corona-Krise so viele Medikamente hergestellt…

Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know

Teva Pharmaceutical Industries Ltd. (TEVA) closed at $9.54 in the latest trading session, marking a +0.85% move from the prior…

TEVA Pharmaceutical: Hohe Nachfrage - Aktienanalyse

Kulmbach (www.aktiencheck.de) - TEVA Pharmaceutical-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…

Teva, Bayer, Shop Apotheke und Co: Run auf Medikamente!

Viele Verbraucher in Deutschland haben sich aus Sorge um das Coronavirus mit Arzneien eingedeckt. Im März zog die Nachfrage nach…

VIRUS/ROUNDUP 2/Angst vor Corona: Verbraucher decken sich mit Arzneien ein

(neu: Angaben zu Stada) FRANKFURT (dpa-AFX) - Viele Verbraucher in Deutschland haben sich…

VIRUS/ROUNDUP: Verbraucher decken sich mit Arzneien ein

FRANKFURT (dpa-AFX) - Viele Verbraucher in Deutschland haben sich aus Sorge um das Coronavirus mit Arzneien…

VIRUS/Angst vor Corona: Verbraucher decken sich mit Arzneien ein

FRANKFURT (dpa-AFX) - Viele Verbraucher in Deutschland haben sich aus Sorge vor dem Coronavirus mit Arzneien…

TEVA Pharmaceutical: Hochstufung und neues Kursziel

Zürich (www.aktiencheck.de) - Rating-Update: Kevin Caliendo, Analyst der UBS, stuft die Aktie der Biotechkonzerns TEVA Pharmaceutical Industries Ltd. (ISIN: US8816242098,…

UBS reiterates Tevas Buy rating but cuts price target

UBS does not see the Israeli pharmaceutical company getting seriously hurt by the Covid-19 pandemic....…

Teva Analyst Says Shares Are Pricing In Too Much Risk

Teva Pharmaceutical Industries Ltd (NYSE: TEVA), which is beset by fundamental and legal woes, is entering a recovery phase, according…

UBS still bullish on Teva despite trimming fair value target; shares up 9%

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

US court upholds validity of Tevas Ajovy patents

The US Patent Trial and Appeal Board has rejected Eli Lillys appeal against the validity of Tevas patents for its…

UPDATE 3-U.S. court rules for Teva in migraine patent dispute with Eli Lilly

Teva Pharmaceutical Industries Ltd on Tuesday won a ruling from a U.S. administrative court that could help it fend off competition from Eli…

UPDATE 2-U.S. court rules for Teva in migraine patent dispute with Eli Lilly

Teva Pharmaceutical Industries Ltd on Tuesday won a ruling from a U.S. administrative court that could help it fend off competition from Eli…

UPDATE 1-U.S. court rules for Teva in migraine patent dispute with Eli Lilly

Teva Pharmaceutical Industries Ltd on Tuesday won a ruling from a U.S. administrative court that could help it fend off competition from Eli…

U.S. court rules for Teva in migraine patent dispute with Eli Lilly

Teva Pharmaceutical Industries Ltd on Tuesday won a ruling from a U.S. administrative court that helps preserve its rights to…

The Zacks Analyst Blog Highlights: Novartis, Teva, Gilead and AbbVie

The Zacks Analyst Blog Highlights: Novartis, Teva, Gilead and AbbVie...…

Teva prevails in migraine patent dispute; shares up 9%

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva prevails in migraine patent dispute with Lilly; shares up 9%

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Medizinaltechnik - Autoinjektor von Ypsomed wird von Teva für Migräne-Medikament verwendet

Die Medizinaltechnikgruppe Ypsomed meldet einen Erfolg von der Produktefront: Der Generikahersteller Teva hat sein Migräne-Medikament AJOVY in einer neuen Verabreichungsform…

Teva Pharmaceutical Industries Ltd. (TEVA) Gains But Lags Market: What You Should Know

Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $7.90, moving +0.77% from the previous trading session....…

Teva sends hundreds of Israeli employees on paid leave

The days of paid leave will not be deducted from the employees regular vacation days....…

Teva CEO Kare Schultz agrees contract extension

Teva announced that Schultz had agreed to extend the validity of his deal with Teva from November 2022 until November…

Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know

In the latest trading session, Teva Pharmaceutical Industries Ltd. (TEVA) closed at $7.26, marking a +1.26% move from the previous…

Teva Donating More Than 10 Million Doses of Hydroxychloroquine as Potential COVID-19 Treatment

Preliminary studies done in China suggest the decades-old malaria drug could inhibit the growth of the novel coronavirus....…

UPDATE 2-Novartis to donate malaria drug in fight against coronavirus

* Mylan, Teva, Bayer also make pledges (Adds comments from U.S. news conference)...…

UPDATE 1-Novartis to donate malaria drug in fight against coronavirus

* Mylan, Teva, Bayer also make pledges (Adds details, background)...…

Why Tevas Stock Is Trading Higher Today

Teva Pharmaceutical Industries (NYSE: TEVA) shares were trading higher on Friday. On Thursday, U.S. President Trump said during the White Houses…

Teva Donates 6 Million Tablets of Malaria Drug to Fight Coronavirus in U.S.

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mylan, Teva in Focus As Chloroquine Being Tested for Coronavirus

Malaria drug, chloroquine, is being tested for the treatment of patients infected with COVID-19. Generic makers, Mylan and Teva ramp…

Benzinga Pros Stock To Watch For Fri., Mar. 20, 2020: TEVA

Benzinga Pros Stocks To Watch For Friday Teva Pharmaceutical Industries (TEVA) - Shares spiked nearly 4% to set a morning high around…

Teva to donate 6 million doses of hydroxychloroquine, floated as a potential treatment for COVID-19

Shares of Teva Pharmaceutical Industries Ltd. gained 13% in premarket trading on Friday following a Thursday night announcement that…

Teva donates potential Covid-19 drug

The Israeli pharmaceutical company will ship 10 million tablets through wholesalers to US hospitals by the end of the month....…

Israels Teva plans to donate 6 million tablets of malaria drug touted by Trump as a potential treatment for the coronavirus, to help U.S. hospitals meet a potential surge in demand

Um den gesamten Artikel unter trib.al zu lesen, klicken Sie bitte auf die Überschrift...…

Teva to donate 6M doses of malaria drug for coronavirus use

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva Pharmaceuticals Near 20-Year Lows

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Celltrion launches Herceptin biosimilar in US

Celltrion Healthcare launched breast cancer and stomach cancer treatment Herzuma in the US market through local partner Teva Pharmaceutical. …

Teva launches Herceptin biosimilar in U.S.

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Teva, Celltrion launch Herceptin biosimilar in US

Teva and Celltrions Herzuma will be sold at a 10% discount on the price of the original oncological drug....…

UKs NICE on board with Tevas Ajovy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Teva Gained Nearly 11% in February

The long-beleaguered drugmaker may finally be positioned for growth again....…

Perrigo launches generic version of Tevas ProAir

ProAir HFA is one of Tevas important branded products....…

TEVA Pharmaceutical: Downgrade

St. Louis (www.aktiencheck.de) - Rating-Update: Ashtyn Evans, Analyst von Edward Jones, stuft die Aktie des Biotechkonzerns TEVA Pharmaceutical Industries Ltd. (ISIN:…

Teva Pharmaceutical Gets a Taste of Its Own Medicine As the FDA Approves a Generic of Its Asthma Drug

A generic approval for Perrigo of Tevas ProAir HFA was highly anticipated....…

The Zacks Analyst Blog Highlights: Johnson & Johnson, Bayer Aktiengesellschaft, Pfizer, Mylan N.V. and Teva Pharmaceutical Industries

The Zacks Analyst Blog Highlights: Johnson & Johnson, Bayer Aktiengesellschaft, Pfizer, Mylan N.V. and Teva Pharmaceutical Industries...…